NEJM: Semaglutide Evaluated for Pediatric Obesity

WeightControl.com Interview with:
Prof. Dr. Daniel Weghuber
Head of Department
Department of Pediatrics
Paracelsus Medical University
Austria
President of the European Childhood Obesity Group

Prof. Dr. Weghuber

WeightControl.com:  What is the background for this study? 

Response: In this study, researchers looked at the effect of semaglutide on body mass index (BMI) and weight loss compared to a dummy medicine (placebo).

Last Updated on December 15, 2022 by weightcontrol